New Delhi, India

Satyananda Misra


Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • New Delhi, IN (1998)
  • Haryana, IN (2004)

Company Filing History:


Years Active: 1998-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Satyananda Misra

Introduction

Satyananda Misra is a notable inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug preparation. With a total of 3 patents to his name, his work has had a considerable impact on the industry.

Latest Patents

One of his latest patents is a process for the preparation of tolterodine. This invention relates to a cost-effective and industrially advantageous method for producing tolterodine and its pharmaceutically acceptable salts. Another significant patent involves the manufacturing of simvastatin from lovastatin or mevinolinic acid. This process includes treating the starting material with cyclopropyl or butyl amine, which opens the pyranone ring when lovastatin is used. The method allows for the addition of a methyl group to the 2-methylbutyrate side chain, ultimately closing the open pyranone ring to produce simvastatin without the need for protecting and deprotecting the hydroxy groups.

Career Highlights

Satyananda Misra is currently associated with Ranbaxy Laboratories, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in drug formulation and process development has been instrumental in advancing the company's research initiatives.

Collaborations

He has collaborated with notable coworkers such as Yatendra Kumar and Rajesh Kumar Thaper, contributing to various projects that enhance the company's research capabilities.

Conclusion

Satyananda Misra's contributions to pharmaceutical innovations demonstrate his commitment to advancing drug development processes. His patents reflect a deep understanding of chemistry and a dedication to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…